TELA Bio, Inc. Employee-related Liabilities, Current
TELA Bio, Inc. (TELA) had Employee-related Liabilities, Current of $7.16 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:EmployeeRelatedLiabilitiesCurrent · last filed 2026-08-11
- 2026-06-30: Employee-related Liabilities, Current $7.16M.
- 2026-03-31: Employee-related Liabilities, Current $5.76M.
- 2025-12-31: Employee-related Liabilities, Current $7.10M.
- 2025-09-30: Employee-related Liabilities, Current $6.76M.
| Period end | Employee-related Liabilities, Current |
|---|---|
| 2026-06-30 | $7.16M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $5.76M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $7.10M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $6.76M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $6.44M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $5.50M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $7.34M 10-K · filed 2026-03-25 |
| 2024-09-30 | $7.85M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $6.61M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $5.95M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $9.22M 10-K · filed 2025-03-21 |
| 2023-09-30 | $7.09M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $6.24M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $4.50M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $6.42M 10-K · filed 2024-03-22 |
| 2021-12-31 | $4.98M 10-K · filed 2023-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |